OctaPharma Plasma Data Breach – Class Action Investigation
Chimicles Schwartz Kriner & Donaldson-Smith is investigating a potential class action relating to a data breach incident involving Octapharma Plasma, Inc. (“Octapharma’), a pharmaceutical company that collects, tests, and supplies human blood plasma in creation of pharmaceutical products.
Specifically, it is reported that Octapharma experienced a BlackSuit ransomware attack on April 15, 2024 causing a shutdown of the Company’s 150+ US plasma donation centers for several days.
While OctaPharma has yet to confirm the exact scope of the breach and the information that may have been compromised as result, information accessed may have included, but not limited to, the following from blood plasma donors: name, social security numbers, date of birth, and mailing address.
If you believe your personal information may have been compromised as a result of this breach, please fill-out the form provided below.
(*) Indicates required field: When communicating with us through this site or otherwise in connection with a matter for which we do not already represent you, your communication may not be treated as privileged or confidential, and does not create an attorney-client relationship between you and our Firm.
